Hyde Joseph R Iii - Net Worth and Insider Trading
Hyde Joseph R Iii Net Worth
The estimated net worth of Hyde Joseph R Iii is at least $19,503 dollars as of 2024-09-20. Hyde Joseph R Iii is the Director, 10% Owner of Oncternal Therapeutics Inc and owns about 12,266 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $19,503. Details can be seen in Hyde Joseph R Iii's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hyde Joseph R Iii has not made any transactions after 2011-06-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hyde Joseph R Iii
Hyde Joseph R Iii Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hyde Joseph R Iii owns 3 companies in total, including Oncternal Therapeutics Inc (ONCT) , AutoZone Inc (AZO) , and FedEx Corp (FDX) .
Click here to see the complete history of Hyde Joseph R Iii’s form 4 insider trades.
Insider Ownership Summary of Hyde Joseph R Iii
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2014-03-06 | director & 10 percent owner |
| AZO | AutoZone Inc | 2003-09-02 | director |
| FDX | FedEx Corp | 2003-09-03 | director |
Hyde Joseph R Iii Latest Holdings Summary
Hyde Joseph R Iii currently owns a total of 1 stock. Hyde Joseph R Iii owns 12,266 shares of Oncternal Therapeutics Inc (ONCT) as of June 28, 2011, with a value of $19,503.
Latest Holdings of Hyde Joseph R Iii
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2011-06-28 | 12,266 | 1.59 | 19,503 |
Holding Weightings of Hyde Joseph R Iii
Hyde Joseph R Iii Form 4 Trading Tracker
According to the SEC Form 4 filings, Hyde Joseph R Iii has made a total of 0 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 696 shares on June 28, 2011, which cost Hyde Joseph R Iii around $5 Million.
Insider Trading History of Hyde Joseph R Iii
- 1
Hyde Joseph R Iii Trading Performance
GuruFocus tracks the stock performance after each of Hyde Joseph R Iii's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hyde Joseph R Iii is 6.44%. GuruFocus also compares Hyde Joseph R Iii's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hyde Joseph R Iii within 3 months outperforms 14 times out of 26 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hyde Joseph R Iii's insider trading performs compared to the benchmark.
Performance of Hyde Joseph R Iii
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.56 | | | | | |
| Relative Return to S&P 500(%) | 2.31 | | | | | |
Hyde Joseph R Iii Ownership Network
Hyde Joseph R Iii Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Hyde Joseph R Iii is the director & 10 percent owner of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Hyde Joseph R Iii made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 150,000 shares made by James B Breitmeyer , and a net purchase of 30,000 shares made by Richard G Vincent .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 23,880 shares were bought by its insiders, resulting in a net purchase of 22,900 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Hyde Joseph R Iii Mailing Address
Above is the net worth, insider trading, and ownership report for Hyde Joseph R Iii. You might contact Hyde Joseph R Iii via mailing address: Po Box 1152, Memphis Tn 38101-1152.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
